Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia
Samir H. Barghout, Parasvi S. Patel, Xiaoming Wang, et al.
Leukemia (2018) Vol. 33, Iss. 1, pp. 37-51
Closed Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Ubiquitin ligases: guardians of mammalian development
David A. Cruz Walma, Zhuoyao Chen, Alex N. Bullock, et al.
Nature Reviews Molecular Cell Biology (2022) Vol. 23, Iss. 5, pp. 350-367
Open Access | Times Cited: 126
Targeting SUMO Signaling to Wrestle Cancer
Jessie S. Kroonen, Alfred C.O. Vertegaal
Trends in cancer (2020) Vol. 7, Iss. 6, pp. 496-510
Open Access | Times Cited: 89
E1 Enzymes as Therapeutic Targets in Cancer
Samir H. Barghout, Aaron D. Schimmer
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 1-56
Open Access | Times Cited: 82
ByeTAC: Bypassing an E3 Ligase for Targeted Protein Degradation
Eslam M.H. Ali, Cody A. Loy, Darci J. Trader
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 10
Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities
A. Awan, Maryiam Jama Ali Osman, Omar M. Khan
Cells (2025) Vol. 14, Iss. 2, pp. 69-69
Open Access | Times Cited: 1
Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma
Junling Zhuang, Fazal Shirazi, R. K. Singh, et al.
Blood (2019) Vol. 133, Iss. 14, pp. 1572-1584
Open Access | Times Cited: 70
Ubiquitin-Like Modifier Activating Enzyme 1 as a Novel Diagnostic and Prognostic Indicator That Correlates With Ferroptosis and the Malignant Phenotypes of Liver Cancer Cells
Yiru Shan, Guang Yang, Haixia Huang, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 51
Current Methods of Post-Translational Modification Analysis and Their Applications in Blood Cancers
Katie Dunphy, Paul Dowling, Despina Bazou, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1930-1930
Open Access | Times Cited: 51
Pharmacological Modulation of Ubiquitin-Proteasome Pathways in Oncogenic Signaling
Anmol Sharma, Heena Khan, Thakur Gurjeet Singh, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11971-11971
Open Access | Times Cited: 50
A genome-wide CRISPR/Cas9 screen in acute myeloid leukemia cells identifies regulators of TAK-243 sensitivity
Samir H. Barghout, Ahmed Aman, Kazem Nouri, et al.
JCI Insight (2021) Vol. 6, Iss. 5
Open Access | Times Cited: 44
Targeting the Ubiquitin–Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung Cancer
Safa Majeed, Mansi K. Aparnathi, Kevin C. Nixon, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 9, pp. 1966-1978
Open Access | Times Cited: 32
Targeting ubiquitin-activating enzyme induces ER stress–mediated apoptosis in B-cell lymphoma cells
Scott Best, Taylor Hashiguchi, Adam S. Kittai, et al.
Blood Advances (2019) Vol. 3, Iss. 1, pp. 51-62
Open Access | Times Cited: 48
SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243
Yasuhisa Murai, Ukhyun Jo, Junko Murai, et al.
Cancer Research (2021) Vol. 81, Iss. 11, pp. 3067-3078
Open Access | Times Cited: 37
The deubiquitinase (DUB) USP13 promotes Mcl-1 stabilisation in cervical cancer
Ethan L. Morgan, Molly R. Patterson, Diego Barba‐Moreno, et al.
Oncogene (2021) Vol. 40, Iss. 11, pp. 2112-2129
Open Access | Times Cited: 36
UBA1 and DNMT3A mutations in VEXAS syndrome. A case report and literature review
Farah Shaukat, Melissa Hart, Timothy F. Burns, et al.
Modern Rheumatology Case Reports (2021) Vol. 6, Iss. 1, pp. 134-139
Closed Access | Times Cited: 36
Ubiquitination and the Proteasome as Drug Targets in Trypanosomatid Diseases
Marie-José Bijlmakers
Frontiers in Chemistry (2021) Vol. 8
Open Access | Times Cited: 35
Self-reversal facilitates the resolution of HMCES DNA-protein crosslinks in cells
Jorge Rua-Fernandez, Courtney A. Lovejoy, Kavi P.M. Mehta, et al.
Cell Reports (2023) Vol. 42, Iss. 11, pp. 113427-113427
Open Access | Times Cited: 14
Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts
Yasuhiro Arakawa, Ukhyun Jo, Suresh Kumar, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 3, pp. 834-848
Open Access | Times Cited: 5
Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies
Zhe Sha, Tamara Blyszcz, Román González‐Prieto, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 42, pp. 15218-15234
Open Access | Times Cited: 42
Ubiquitin activation is essential for schizont maturation in Plasmodium falciparum blood-stage development
Judith L. Green, Yang Wu, Vesela Encheva, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 6, pp. e1008640-e1008640
Open Access | Times Cited: 37
Proteomic characterization of post-translational modifications in drug discovery
Linhui Zhai, Kai‐Feng Chen, Bingbing Hao, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 12, pp. 3112-3129
Open Access | Times Cited: 23
USP24 promotes autophagy-dependent ferroptosis in hepatocellular carcinoma by reducing the K48-linked ubiquitination of Beclin1
Jiahui Cao, Shitao Wu, Senfeng Zhao, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 4
The NF-κB Pharmacopeia: Novel Strategies to Subdue an Intractable Target
Daniela Verzella, Jessica Cornice, Paola Arboretto, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2233-2233
Open Access | Times Cited: 18
MAGL targeted PROTAC degrader simultaneously enhances P53 for synergistic treatment of glioblastoma stem cell
Zheng Yuan, Meixia Guo, Yue Zhang, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
UBA protein family: An emerging set of E1 ubiquitin ligases in cancer—A review
Huhu Zhang, Fulin Sun, Hongyu Cao, et al.
International Journal of Biological Macromolecules (2025), pp. 142277-142277
Closed Access
Page 1 - Next Page

Scroll to top